Furthermore, structural modifications in the protein have been described, and it has been recommended to consider SLC25A3 sequencing in patients with isolated cardiomyopathy, even in those without generalized skeletal myopathy or lactic acidosis [150]. The gene discussed is SLC25A3; the disease is skeletal muscle disorder.